Home・Список акций・OPKO Health Inc

OPKO Health Inc

Закрыт

СекторЗдравоохранение

1.62 1.25

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.5899999999999999

Макс.

1.63

Ключевые показатели
By Trading Economics
Доход	46M -8.4M
Продажи	39M 164M
Прибыль на акцию	-0.01
Рентабельность продаж	-5.145
Сотрудники	2,275
EBITDA	43M 15M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+91.51% upside

Дивиденды
By Acuity
Следующий отчет о доходах	28 окт. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	310M 1.2B
Предыдущая цена открытия	0.37
Предыдущая цена закрытия	1.62

OPKO Health Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

27 окт. 2026 г., 19:56 UTC

Event

News

OPKO Health's subsidiary OPKO Biologics has initiated a Phase 1/2a clinical trial for OPK-8801001, a long-acting growth hormone receptor antagonist for acromegaly.

26 окт. 2026 г., 21:21 UTC

OPKO Health Inc is advancing in after-market trading, reaching a peak return of 1.17% since Monday's close and significantly above its 20-day moving average.

23 окт. 2026 г., 23:02 UTC

OPKO Health Inc shares are trading lower in after-market hours, continuing a decline from Friday's close without any recovery during the session.

22 окт. 2026 г., 19:33 UTC

OPKO Health Inc is trading higher, driven by significant gains in the Health Care Services sub-sector, despite earlier pulling back from a session peak.

21 окт. 2026 г., 23:51 UTC

OPKO Health Inc is advancing in after-market trading, showing strong upward momentum and positioning the stock above its 20-day moving average.

20 окт. 2026 г., 23:06 UTC

OPKO Health Inc shares advanced modestly in after-market trading, remaining well above its 20-day moving average and near the upper end of its one-month range.

19 окт. 2026 г., 23:01 UTC

OPKO Health Inc shares declined in after-market trading, continuing a downward trend as the NAHB Housing Market Index fell to 29, the lowest since June 2012.

16 окт. 2026 г., 23:51 UTC

OPKO Health Inc shares declined during after-market hours, falling significantly after initially showing positive returns and remaining below their 20-day moving average.

15 окт. 2026 г., 23:32 UTC

OPKO Health Inc's shares advanced during after-market hours on Thursday, diverging from a recent trend of higher daily closes despite currently trading lower.

14 окт. 2026 г., 20:07 UTC

OPKO Health Inc. is advancing during Wednesday's trading session, rebounding significantly after an initial dip amid notably positive broader market performance.

13 окт. 2026 г., 19:31 UTC

OPKO Health Inc shares fell sharply, currently at their lowest point of the day and well below the 20-day moving average, continuing a decline since Monday.

12 окт. 2026 г., 20:06 UTC

OPKO Health Inc shares are modestly lower, ending near the lower end of their one-month trading range and significantly below the 20-day moving average.

9 окт. 2026 г., 22:01 UTC

OPKO Health Inc declined sharply in after-market trading, moving well below its 20-day moving average and near the lower end of its one-month range.

8 окт. 2026 г., 20:13 UTC

OPKO Health Inc shares advanced during after-market hours.

7 окт. 2026 г., 20:00 UTC

OPKO Health Inc shares fell sharply, reaching their lowest point of the day and trading well below the 20-day moving average amid ongoing market weakness.

6 окт. 2026 г., 22:20 UTC

OPKO Health Inc saw a notable increase in after-market trading, recovering from an initial dip and marking its highest cumulative return since Tuesday's close.

5 окт. 2026 г., 20:06 UTC

OPKO Health Inc closed higher on Monday, showing a modest advance and peaking in late morning, while remaining around the midpoint of its one-month trading range.

3 окт. 2026 г., 00:01 UTC

OPKO Health Inc is trading lower in after-market hours, continuing a trend of four consecutive sessions finishing lower amid ongoing performance weakness.

2 окт. 2026 г., 23:41 UTC

OPKO Health Inc is trading lower in after-market hours, continuing a trend of declines following a sharp drop from its peak shortly after the market closed.

1 окт. 2026 г., 20:02 UTC

OPKO Health Inc shares fell sharply, trading well below its 20-day moving average and near the lower end of its one-month range.

29 сент. 2026 г., 20:07 UTC

OPKO Health Inc is trading modestly higher, currently around the midpoint of its one-month range and above its 20-day moving average.

28 сент. 2026 г., 19:46 UTC

OPKO Health Inc shares fell amid a broader market decline, remaining above the 20-day moving average and around the midpoint of its one-month range.

25 сент. 2026 г., 20:07 UTC

OPKO Health Inc is trading higher amid a broader market rally, which closed above its 20-day moving average despite ongoing economic concerns.

24 сент. 2026 г., 23:01 UTC

OPKO Health Inc is trading modestly higher in after-market hours, rebounding from three consecutive lower daily closes amid mixed performance in the health care services sector.

23 сент. 2026 г., 21:50 UTC

OPKO Health Inc declined in after-market trading, shifting from a positive return to a negative one since Wednesday's close, settling at the day's lowest point.

22 сент. 2026 г., 23:01 UTC

OPKO Health Inc is trading lower in after-market hours, declining notably from its peak, amid concerns following the unexpected drop in the Richmond Fed Manufacturing Index.

21 сент. 2026 г., 23:10 UTC

OPKO Health Inc's shares declined modestly in after-market trading on Monday, falling to their lowest point of the day despite remaining above the 20-day moving average.

17 сент. 2026 г., 20:07 UTC

OPKO Health Inc's stock is roughly flat, remaining above its 20-day moving average and near the upper end of its one-month trading range.

16 сент. 2026 г., 19:03 UTC

OPKO Health Inc is seeing upward movement, currently trading significantly above its 20-day moving average and near the upper end of its one-month range.

15 сент. 2026 г., 23:11 UTC

OPKO Health Inc shares are higher in after-market trading, advancing from a low of 1.28% to a high of 1.92% since Tuesday's close.

Сравнение c конкурентами

Изменение цены

OPKO Health Inc Прогноз

Целевая цена

By TipRanks

91.51% рост

Прогноз на 12 месяцев

Средняя 3.083 USD 91.51%

Максимум 4 USD

Минимум 2.25 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для OPKO Health Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

3 ratings

Покупка

Удержание

Продажа

Основано на мнении 3 аналитиков, присваивавших рейтинги акциям OPKO Health Inc – Данные за последние 3 месяца.

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.